Cite
HARVARD Citation
Cabel, L. et al. (n.d.). 371 Potential benefit of pharmacokinetically-guided dosing strategy for the decision making in cancer patients treated with sunitinib. European journal of cancer. pp. S78-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Cabel, L. et al. (n.d.). 371 Potential benefit of pharmacokinetically-guided dosing strategy for the decision making in cancer patients treated with sunitinib. European journal of cancer. pp. S78-. [Online].